HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54
Published March 13, 2013 · Recall initiated: October 22, 2012
Summary
FDA records drug Class II recall D-184-2013, published March 13, 2013 and initiated October 22, 2012. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 11,412 bags; Lot: Lot # 10-199-JT Exp. 10/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
What to do
Voluntary: Firm initiated · Letter
Get an email if HEXTEND has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HEXTEND
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot # 10-199-JT Exp. 10/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,March 13, 2013
- FDAWell at Walgreens Wal-Tussin CF Max, MAXIMUM STRENGTH ADULT NON-DROWSY, Multi-Symptom Cold, (dextromethorphanMarch 13, 2013
- FDAMontelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b)March 13, 2013
- FDARite Aid Maximum Strength Tussin Cough & Cold Mucus Relief CF, (dextromethorphan HBr 10 mg, guaifenesin 200March 13, 2013
- FDAABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America PharmaceuticalMarch 13, 2013
- FDASelect Brand Cough Control CF Max, Maximum Strength for MUCUS RELIEF, (dextromethorphan HBr 10 mg, guaifenesinMarch 13, 2013
Questions about this recall
Was HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54 recalled?
Yes. FDA published recall D-184-2013 on March 13, 2013. Reported hazard: Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HEXTEND.